2023-24 Guide to Medications for the Treatment of Diabetes Mellitus

The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.

This guide also includes chapters on medications to manage comorbidities such as:

    •     Neuropathy
    •     Nephropathy
    •     Retinopathy
    •     Hypoglycemia
    •     Obesity
    •     Depression

Sommario

1.    Pharmacologic Therapy for Type 1 Diabetes    1
2.    Management of Hyperglycemia in Type 1 Diabetes Mellitus    15
Joshua J. Neumiller, PharmD, CDE, FADCES, FASCP
3.    Insulin    34
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, and
Kimberly C. ­McKeirnan, PharmD, BCACP
4.    Pharmacologic Therapy for Type 2 Diabetes    56
5.    Overview of Medications Used to Treat Type 2 Diabetes    79
John R. White, Jr., PA-C, PharmD
6.    Biguanides    94
Peggy Soule Odegard, BSPharm, PharmD, CDCES, and
Kam L. Capoccia, PharmD, BCPS, CDCES
7.    Thiazolidinediones    123
Kam L. Capoccia, PharmD, BCPS, CDCES, and
Peggy Soule Odegard, BSPharm, PharmD, CDCES
8.    Sulfonylureas     145
Lisa Kroon, PharmD, and Crystal Zhou, PharmD
9.    Glinides    160
Lisa Kroon, PharmD, and Crystal Zhou, PharmD
10.    SGLT2 Inhibitors    172
John R. White, Jr., PA-C, PharmD
11.    α-Glucosidase Inhibitors    190
Kimberly C. McKeirnan, PharmD, BCACP, and
Nicole M. Rodin, PharmD, MBA
12.    Dipeptidyl Peptidase-4 (DPP-4) Inhibitors    198
Kimberly C. McKeirnan, PharmD, BCACP,
and Joshua J. Neumiller, PharmD, CDE, FADCES, FASCP
13.    Glucagon-Like Peptide-1 Receptor Agonists    213
Jennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADM
14.    Pramlintide    238
Jennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADM
15.    Bile Acid Sequestrants    250
Christina R. Buchman, PharmD, BCACP
16.    Dopamine-2 Receptor Agonists    260
Christina R. Buchman, PharmD, BCACP
17.    Cardiovascular Disease and Risk Management    267
18.    Chronic Kidney Disease and Risk Management    337
19.    Retinopathy, Neuropathy, and Foot Care    362
20.    Hypertension    390
Cheyenne Frazier, PharmD, PhC, BCACP
21.    Lipids     407
Cheyenne Frazier, PharmD, PhC, BCACP
22.    Antiplatelets    425
Megan Willson, PharmD, BCPS, and
Kimberly C. McKeirnan, PharmD, BCACP
23.    Medications for Smoking Cessation    441
Anne P. Kim, PharmD, MPH, MIT
24.    Medications for the Management of Neuropathy    466
Damianne Brand-Eubanks, PharmD
25.    Medications for the Management of Nephropathy    483
Emmeline Tran, PharmD
26.    Medications for the Management of Retinopathy    516
Emmeline Tran, PharmD
27.    Medications for the Management of Depression    540
Megan Willson, PharmD, BCPS
28.    Medications for the Management of Hypoglycemia    552
Megan Giruzzi, PharmD, BCPS
29.    Medications for the Management of Obesity    565
Nicholas R. Giruzzi, PharmD, BCPS
30.    Immunizations and Diabetes    594
Kimberly C. McKeirnan, PharmD, BCACP, and
Nicole M. Rodin, PharmD, MBA
Index    602

Info autore

John R. White, Jr., PA-C, PharmD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at the Washington State University College of Pharmacy. Dr. White is the author of three books, over 30 book chapters, and more than 150 manuscripts on diabetes medications. In addition to his teaching responsibilities at the university, he is a sought-after speaker and has given over 330 lectures at domestic and international conferences. He has been on the editorial boards of many diabetes-related scholarly journals and is currently Associate Editor of Clinical Diabetes.

Riassunto

The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.

Dettagli sul prodotto

• Autori: John R. (EDT) White
• Con la collaborazione di: John R. White (Editore)
• Editore: American diabetes association
• Lingue: Inglese
• Formato: Tascabile
• Pubblicazione: 22.08.2023, ritardato
• EAN: 9781580407649
• ISBN: 978-1-58040-764-9
• Pagine: 658
• Dimensioni: 146 mm x 222 mm x 38 mm
• Categorie: Guide e manuali > Mangiare e bere > Cucina sana, cucina salutistica; MEDICAL / Clinical Medicine, MEDICAL / Pharmacology, MEDICAL / Education & Training, HEALTH & FITNESS / Diseases & Conditions / Diabetes